Indofarma Tbk. vs Sumber Mineral Global Abadi Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Sumber Mineral Global Abadi Tbk. trades at Rp88 (market cap 778.75B, 4.75M 24h volume). The key difference: Sumber Mineral Global Abadi Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | SMGA | |
|---|---|---|
Market Cap | 390.51B | 778.75B |
Volume | — | 4.75M |
Lot | — | 47.55K |
Turnover | — | 416.69M |
Average Price | — | 87.64 |
Value | — | 416.69M |
Indicative Equilibrium Price | — | 88 |
Indicative Equilibrium Volume | — | 407 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Sumber Mineral Global Abadi Tbk (the Company) was established based on Notarial Deed No. 2 dated October 19, 2016 of Selina Bertha Eny, S.H., a notary in South Tanggerang. The Company started its commercial operations in 2016. The Company’s immediate and ultimate parententities are PT Sumber Global Energy Tbk and PT Sumbermas Inti Energi, respectively, both entities domiciled in Jakarta. The controlling interest of the Company is PT Sumber Global Energy Tbk.
Read more on SMGA →